Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh J B Goodman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Clinical Practice. Cardiovascular Medicine|February 1, 2006
Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosisBen L C Wright, Andrew A Grace, Hugh J B Goodman
Biological Trace Element Research|September 7, 2018
Comparative Safety and Pharmacokinetic Evaluation of Three Oral Selenium Compounds in Cancer PatientsStephen O Evans, Gregory M Jacobson, Hugh J B Goodman, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|December 16, 2019
Comparison of three oral selenium compounds in cancer patients: Evaluation of differential pharmacodynamic effects in normal and malignant cellsStephen O Evans, Gregory M Jacobson, Hugh J B Goodman, et al.
Blood|September 23, 2006
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosisAshutosh D Wechalekar, Hugh J B Goodman, Helen J Lachmann, et al.
Blood|August 19, 2008
AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcomeAshutosh D Wechalekar, Helen J Lachmann, Hugh J B Goodman, et al.
British Journal of Haematology|July 11, 2006
Outcome of autologous stem cell transplantation for AL amyloidosis in the UKHugh J B Goodman, Julian D Gillmore, Helen J Lachmann, et al.
The New England Journal of Medicine|June 8, 2007
Natural history and outcome in systemic AA amyloidosisHelen J Lachmann, Hugh J B Goodman, Janet A Gilbertson, et al.
Arthritis and Rheumatism|May 30, 2006
AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two casesHelen J Lachmann, Hugh J B Goodman, Peter A Andrews, et al.
British Journal of Haematology|January 13, 2010
Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosisJulian D Gillmore, Glenys A Tennent, Winston L Hutchinson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Clinical Practice. Cardiovascular Medicine|February 1, 2006
Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosisBen L C Wright, Andrew A Grace, Hugh J B Goodman
Biological Trace Element Research|September 7, 2018
Comparative Safety and Pharmacokinetic Evaluation of Three Oral Selenium Compounds in Cancer PatientsStephen O Evans, Gregory M Jacobson, Hugh J B Goodman, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|December 16, 2019
Comparison of three oral selenium compounds in cancer patients: Evaluation of differential pharmacodynamic effects in normal and malignant cellsStephen O Evans, Gregory M Jacobson, Hugh J B Goodman, et al.
Blood|September 23, 2006
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosisAshutosh D Wechalekar, Hugh J B Goodman, Helen J Lachmann, et al.
Blood|August 19, 2008
AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcomeAshutosh D Wechalekar, Helen J Lachmann, Hugh J B Goodman, et al.
British Journal of Haematology|July 11, 2006
Outcome of autologous stem cell transplantation for AL amyloidosis in the UKHugh J B Goodman, Julian D Gillmore, Helen J Lachmann, et al.
The New England Journal of Medicine|June 8, 2007
Natural history and outcome in systemic AA amyloidosisHelen J Lachmann, Hugh J B Goodman, Janet A Gilbertson, et al.
Arthritis and Rheumatism|May 30, 2006
AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two casesHelen J Lachmann, Hugh J B Goodman, Peter A Andrews, et al.
British Journal of Haematology|January 13, 2010
Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosisJulian D Gillmore, Glenys A Tennent, Winston L Hutchinson, et al.
Pageof 1